tirzepatide ketoacidosis Risk in Non-diabetic Patients Using Semaglutide Versus for Obesity: A Disproportionality Analysis of the FDA Adverse Event Reporting System Diabetes Distilled: Diabetic ketoacidosis with

Semaglutide is often optimized to maximize weight loss, yet it remains unclear whether long-term cardiovascular benefit is more closely associated with achieved weight reduction or therapeutic exposure

Semaglutide might offer a novel treatment pathway for alcohol use disorder in those with comorbid obesity

We present the case of a 14-year-old female patient with autism, developmental delay, and obesity managed with semaglutide who presented for esophagogastroduodenoscopy and colonoscopy

Reimagined indulgences and innovative textures are key to capturing a growing consumer base.

Exploring the connection between Wegovy and IBS symptoms